SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-219398
Filing Date
2022-08-12
Accepted
2022-08-12 08:16:21
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 d390218d424b5.htm 424B5 440583
2 GRAPHIC g390218g00a63.jpg GRAPHIC 148695
3 GRAPHIC g390218g01a01.jpg GRAPHIC 591302
4 GRAPHIC g390218g01a42.jpg GRAPHIC 599526
5 GRAPHIC g390218g04a37.jpg GRAPHIC 32281
6 GRAPHIC g390218g22v52.jpg GRAPHIC 116631
  Complete submission text file 0001193125-22-219398.txt   2472076
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-263370 | Film No.: 221157906
SIC: 2834 Pharmaceutical Preparations